{"denoms":[{"counts":[{"groupId":"BG000","value":"461"},{"groupId":"BG001","value":"230"},{"groupId":"BG002","value":"691"}],"units":"Participants"}],"groups":[{"description":"Participants received 5 mg of fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).","id":"BG000","title":"Fruquintinib + BSC Group"},{"description":"Participants received placebo matched to fruquintinib oral capsule in combination with BSC once daily for 3 weeks of continuous dosing followed by a 1-week break during a treatment cycle (Each cycle length was 28 days).","id":"BG001","title":"Placebo + BSC Group"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.41","value":"62.2"},{"groupId":"BG001","spread":"9.67","value":"62.4"},{"groupId":"BG002","spread":"10.16","value":"62.2"}]}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"216"},{"groupId":"BG001","value":"90"},{"groupId":"BG002","value":"306"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"245"},{"groupId":"BG001","value":"140"},{"groupId":"BG002","value":"385"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"34"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"405"},{"groupId":"BG001","value":"202"},{"groupId":"BG002","value":"607"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"36"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"50"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"43"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"61"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"7"},{"groupId":"BG002","value":"20"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"5"}],"title":"Native Hawaiian or Other"},{"measurements":[{"groupId":"BG000","value":"367"},{"groupId":"BG001","value":"192"},{"groupId":"BG002","value":"559"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"5"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"7"}],"title":"Other"},{"measurements":[{"groupId":"BG000","value":"2"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"}],"title":"Multiple races"},{"measurements":[{"groupId":"BG000","value":"28"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"36"}],"title":"Not reported/unknown"}],"title":"Race"}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race/Ethnicity, Customized","unitOfMeasure":"Participants"}],"populationDescription":"Intent-to-Treat (ITT) population included all randomized participants."}